User profiles for Shaun H Pennington

Shaun Harry Pennington

Liverpool School of Tropical Medicine
Verified email at lstmed.ac.uk
Cited by 1161

Prioritization of anti‐SARS‐Cov‐2 drug repurposing opportunities based on plasma and target site concentrations derived from their established human …

…, G Aljayyoussi, SH Pennington… - Clinical …, 2020 - Wiley Online Library
There is a rapidly expanding literature on the in vitro antiviral activity of drugs that may be
repurposed for therapy or chemoprophylaxis against severe acute respiratory syndrome‐…

Controlled Human Infection and Rechallenge with Streptococcus pneumoniae Reveals the Protective Efficacy of Carriage in Healthy Adults

…, N Green, AKA Wright, SH Pennington… - American journal of …, 2013 - atsjournals.org
Rationale: The immunological and protective role of pneumococcal carriage in healthy adults
is not known, but high rates of disease and death in the elderly are associated with low …

First human challenge testing of a pneumococcal vaccine. Double-blind randomized controlled trial

…, JF Gritzfeld, CA Hancock, SH Pennington… - American journal of …, 2015 - atsjournals.org
Rationale: New vaccines are urgently needed to protect the vulnerable from bacterial pneumonia.
Clinical trials of pneumonia vaccines are slow and costly, requiring tens of thousands …

Dose prediction for repurposing nitazoxanide in SARS‐CoV‐2 treatment or chemoprophylaxis

…, G Aljayyoussi, SH Pennington… - British Journal of …, 2021 - Wiley Online Library
Background Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been
declared a global pandemic and urgent treatment and prevention strategies are needed. …

Experimental human pneumococcal carriage

…, AD Wright, AM Collins, SH Pennington… - JoVE (Journal of …, 2013 - jove.com
Experimental human pneumococcal carriage (EHPC) is scientifically important because
nasopharyngeal carriage of Streptococcus pneumoniae is both the major source of transmission …

Therapeutic potential of nitazoxanide: an appropriate choice for repurposing versus SARS-CoV-2?

…, RKR Rajoli, G Aljayyoussi, SH Pennington… - ACS infectious …, 2020 - ACS Publications
The rapidly growing COVID-19 pandemic is the most serious global health crisis since the “Spanish
flu” of 1918. There is currently no proven effective drug treatment or prophylaxis for …

Polysaccharide-specific memory B cells predict protection against experimental human pneumococcal carriage

SH Pennington, S Pojar, E Mitsi, JF Gritzfeld… - American journal of …, 2016 - atsjournals.org
Rationale: We have previously demonstrated that experimental pneumococcal carriage
enhances immunity and protects healthy adults against carriage reacquisition after rechallenge …

SARS-CoV-2 infects an upper airway model derived from induced pluripotent stem cells

…, EI Patterson, A Casas-Sanchez, SH Pennington… - Stem …, 2021 - academic.oup.com
… [Correction added on 10 July 2021, after first online publication: Author name Shaun H.
Penington has been changed to Shaun H. Pennington and Ivo Djidrovksi has been changed to …

[HTML][HTML] Age-differential CD13 and interferon expression in airway epithelia affect SARS-CoV-2 infection-Effects of vitamin D

F Sposito, SH Pennington, CAW David, J Duggan… - Mucosal …, 2023 - Elsevier
… Author links open overlay panel Francesca Sposito 1 , Shaun H. Pennington 2 , Christopher
AW David 3 , Jack Duggan 2 , Sarah Northey 1 , Giancarlo A. Biagini 2 , Neill J. Liptrott 3 , …

[HTML][HTML] Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from …

C Jin, MM Gibani, SH Pennington, X Liu… - PLoS neglected …, 2019 - journals.plos.org
Background The treatment of enteric fever is complicated by the emergence of antimicrobial
resistant Salmonella Typhi. Azithromycin is commonly used for first-line treatment of …